Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

Presentation TCT Abstracts Posters 2018

Incidence of Clopidogrel Resistance Among South Indian Population Undergoing PCI-A Single Centre Genomic Study of CYP2C19 Polymorphism

Presenter: R. Anantharaman

September 25, 2018

Presentation TCT Abstracts Posters 2018

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

Presenter: Gerard Devlin

September 25, 2018

Presentation JIM 2018

Case: Immediate PCI + downstream clopidogrel

Presenter: Giuseppe Tarantini

February 23, 2018

Presentation JIM 2018

Clinical Case: Management of Long-Term DAPT

Presenter: Ugo Limbruno

February 23, 2018

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presenter: Christoph Varenhorst

October 18, 2013

Presentation

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Presenter: Yongjun Wang

June 26, 2013

Presentation

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg W. Stone

March 26, 2013

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Advertisement

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Incidence of Clopidogrel Resistance Among South Indian Population Undergoing PCI-A Single Centre Genomic Study of CYP2C19 Polymorphism

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

Case: Immediate PCI + downstream clopidogrel

Clinical Case: Management of Long-Term DAPT

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content